117 related articles for article (PubMed ID: 7038840)
1. Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity.
Schrumpf E; Linnestad P; Nygaard K; Giercksky KE; Fausa O
Scand J Gastroenterol; 1981; 16(8):1009-14. PubMed ID: 7038840
[TBL] [Abstract][Full Text] [Related]
2. Effect of jejunoileal bypass operation and Billroth II resection on postprandial plasma pancreatic polypeptide release.
Jorde R; Burhol PG
Scand J Gastroenterol; 1982 Aug; 17(5):613-7. PubMed ID: 7178824
[TBL] [Abstract][Full Text] [Related]
3. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
[TBL] [Abstract][Full Text] [Related]
4. Meal stimulated gastrin and pancreatic polypeptide levels before and after partial gastric transection for morbid obesity.
Shulkes A; Allen RD; Hardy KJ
Aust N Z J Med; 1982 Feb; 12(1):27-30. PubMed ID: 6952836
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.
Eddes EH; Verkijk M; Gielkens HA; Biemond I; Bemelman W; Lamers CB; Masclee AA
Int J Pancreatol; 2001; 29(3):173-80. PubMed ID: 12067221
[TBL] [Abstract][Full Text] [Related]
6. The effect of gastric bypass operation on glucose tolerance in obesity.
Schrumpf E; Bergan A; Djøseland O; Fausa O; Flaten O; Skagen DW; Tronier B
Scand J Gastroenterol Suppl; 1985; 107():24-31. PubMed ID: 3885381
[TBL] [Abstract][Full Text] [Related]
7. Meal-induced pancreatic polypeptide release in a validated pancreatic denervation model: a role for the distal pancreas?
Fink AS; DeMar AR; Gettys TW; Taylor IL
Pancreas; 1990 May; 5(3):323-9. PubMed ID: 2343045
[TBL] [Abstract][Full Text] [Related]
8. [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass].
Civalleri D; Bloom SR; Sarson DL; Gianetta E; Bonalumi U; Friedman D; Pitton L; Brignole E; Binda PL; Degrandi R; Scopinaro N
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1929-35. PubMed ID: 7459103
[TBL] [Abstract][Full Text] [Related]
9. Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.
Meryn S; Stein D; Straus EW
Metabolism; 1986 Sep; 35(9):798-802. PubMed ID: 3528741
[TBL] [Abstract][Full Text] [Related]
10. Gastrin secretion before and after gastric bypass surgery for morbid obesity.
Schrumpf E; Giercksky KE; Nygaard K; Fausa O
Scand J Gastroenterol; 1981; 16(6):721-5. PubMed ID: 7034160
[TBL] [Abstract][Full Text] [Related]
11. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
Amland PF; Jorde R; Giercksky KE; Burhol PG
Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
Meryn S; Stein D; Straus EW
Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
[TBL] [Abstract][Full Text] [Related]
13. Impaired pancreatic innervation after selective gastric vagotomy. Reduction of the pancreatic polypeptide response to food and insulin hypoglycemia.
Løvgren NA; Poulsen J; Schwartz TW
Scand J Gastroenterol; 1981; 16(6):811-6. PubMed ID: 7034162
[TBL] [Abstract][Full Text] [Related]
14. Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity.
Miskowiak J; Andersen B; Stadil F; Fahrenkrug J
Regul Pept; 1985 Nov; 12(3):231-6. PubMed ID: 4081128
[TBL] [Abstract][Full Text] [Related]
15. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
16. Meal stimulated neurotensin release following gastric partitioning for morbid obesity.
Shulkes A; Allen RD; Hardy KJ
Aust N Z J Surg; 1983 Apr; 53(2):149-52. PubMed ID: 6576763
[TBL] [Abstract][Full Text] [Related]
17. [Behavior of plasma insulin and GIP in obese patients subjected to biliopancreatic bypass].
Gianetta E; Bloom SR; Sarson DL; Civalleri D; Bonalumi U; Friedman D; Adami GF; Pitton L; Brignole E; Traverso E; Scopinaro N
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1922-8. PubMed ID: 7006641
[TBL] [Abstract][Full Text] [Related]
18. Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction.
Inoue K; Tobe T; Suzuki T; Hosotani R; Kogire M; Fuchigami A; Miyashita T; Tsuda K; Seino Y
Ann Surg; 1987 Aug; 206(2):148-54. PubMed ID: 3606240
[TBL] [Abstract][Full Text] [Related]
19. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.
Mathus-Vliegen EM; de Groot GH
Obes Surg; 2013 May; 23(5):622-33. PubMed ID: 23224567
[TBL] [Abstract][Full Text] [Related]
20. Role of the distal pancreas in pancreatic polypeptide release.
Kuvshinoff BW; DeMar AR; Gettys TW; Taylor IL; Fink AS
Pancreas; 1992; 7(3):339-44. PubMed ID: 1594555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
